Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 19, 16:00
2487.50
21.85 (0.89%)
VOLUME 27,108
LIVE
NSE
Jan 19, 15:59
2490.35
28.85 (1.17%)
VOLUME 240,896
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Nine Months of Dr Reddys Laboratories

------------------- in Rs. Cr. -------------------
Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Net Sales/Income from operations 7,324.70 7,867.00 7,256.17 7,051.60 6,011.37
Other Operating Income 35.00 46.50 66.05 61.33 60.16
Total Income From Operations 7,359.70 7,913.50 7,322.22 7,112.93 6,071.53
EXPENDITURE
Consumption of Raw Materials 1,434.60 1,560.90 1,850.62 1,619.63 1,707.09
Purchase of Traded Goods 502.90 483.70 394.85 335.81 296.01
Increase/Decrease in Stocks -167.20 -74.90 -159.03 -101.92 -174.03
Power & Fuel -- -- -- -- --
Employees Cost 1,431.00 1,261.20 1,106.53 890.63 834.69
Depreciation 545.50 468.30 353.46 281.55 228.22
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 759.70 771.70 840.12 621.38 593.66
R & D Expenses -- -- -- 607.21 465.87
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 1,963.90 1,877.90 1,665.75 1,044.77 980.54
P/L Before Other Inc. , Int., Excpt. Items & Tax 889.30 1,564.70 1,269.92 1,813.87 1,139.48
Other Income 533.20 226.30 147.11 102.71 101.46
P/L Before Int., Excpt. Items & Tax 1,422.50 1,791.00 1,417.03 1,916.58 1,240.94
Interest 41.40 49.50 45.03 59.33 43.80
P/L Before Exceptional Items & Tax 1,381.10 1,741.50 1,372.00 1,857.25 1,197.14
Exceptional Items -- -- -- -- --
P/L Before Tax 1,381.10 1,741.50 1,372.00 1,857.25 1,197.14
Tax 220.00 328.50 264.07 395.84 309.81
P/L After Tax from Ordinary Activities 1,161.10 1,413.00 1,107.93 1,461.41 887.33
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 1,161.10 1,413.00 1,107.93 1,461.41 887.33
Equity Share Capital 82.90 85.30 85.18 85.05 84.92
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 69.55 82.86 65.06 85.95 52.27
Diluted EPS 69.38 82.60 64.77 85.53 52.01
EPS After Extra Ordinary
Basic EPS 69.55 82.86 65.06 85.95 52.27
Diluted EPS 69.38 82.60 64.77 85.53 52.01
Public Share Holding
No Of Shares (Crores) -- -- 9.73 9.76 9.81
Share Holding (%) -- -- 57.11 57.37 57.78
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- 4.34 4.34 4.34
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- -- 25.49 25.53 25.56
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for drreddyslaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.